- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: Camrelizumab til injektion
I alt 26921 resultater
-
Jiangsu HengRui Medicine Co., Ltd.Afsluttet
-
Jiangsu HengRui Medicine Co., Ltd.Rekruttering
-
Sun Yat-sen UniversityRekrutteringNasopharyngealt karcinomKina
-
Huazhong University of Science and TechnologyThe First Affiliated Hospital of Nanchang UniversityRekrutteringLymfom | Tilbagefald/GentagelseKina
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuEsophageal pladecellekarcinom | Progression til PD-1 antistofKina
-
Jiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterende
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Tilmelding efter invitationAvancerede maligne tumorerKina
-
Sun Yat-sen UniversityGuangdong Provincial People's Hospital; Affiliated Cancer Hospital & Institute... og andre samarbejdspartnereRekrutteringNasopharyngealt karcinomKina
-
Zhejiang Cancer HospitalRekrutteringHjernemetastaser | NSCLC trin IV | ImmunterapiKina
-
Vivozon, Inc.AfsluttetPost-operative smerterKorea, Republikken
-
First Affiliated Hospital Xi'an Jiaotong UniversityIkke rekrutterer endnu
-
Vivozon, Inc.Afsluttet
-
Bio-Thera SolutionsRekrutteringAvancerede solide tumorerKina
-
Jiangsu HengRui Medicine Co., Ltd.Tilmelding efter invitation
-
Jiangsu HengRui Medicine Co., Ltd.Afsluttet
-
Jiangsu HengRui Medicine Co., Ltd.Ikke rekrutterer endnu
-
Fidia Farmaceutici s.p.a.RekrutteringDegenerativ disksygdom (DDD)Italien, Schweiz
-
Vifor Fresenius Medical Care Renal PharmaTigermed Consulting Co., LtdAktiv, ikke rekrutterende
-
United States Naval Medical Center, San DiegoCEL-SCI CorporationAfsluttet
-
First Affiliated Hospital Xi'an Jiaotong UniversityRekrutteringAvanceret hepatocellulært karcinomKina
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterende
-
Jiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterendeAdjuverende terapi hos patienter med hepatocellulært karcinom (HCC) med høj risiko for tilbagefald efter kurativ resektion eller ablationKina
-
Qian ChuJiangsu HengRui Medicine Co., Ltd.Rekruttering
-
Fuzhou General HospitalRekrutteringEsophageal pladecellekarcinomKina
-
Beijing Anzhen HospitalRekrutteringMyokardieinfarktKina
-
Fujian Medical University Union HospitalIkke rekrutterer endnuKemoterapi | StråleterapiKina
-
Henan Cancer HospitalRekrutteringAvanceret gastrisk adenocarcinomKina
-
Shanghai Chest HospitalIkke rekrutterer endnu
-
Sun Yat-sen UniversityRekrutteringHypopharynx kræft | Immunterapi | InduktionskemoterapiKina
-
Jiangsu HengRui Medicine Co., Ltd.AfsluttetBrystkræft | Solid tumor | Gastrointestinal kræftKina
-
Tang-Du HospitalRekruttering
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRekrutteringLevertransplantation | Hepatocellulært karcinomKina
-
Jiangsu HengRui Medicine Co., Ltd.AfsluttetNasopharyngealt karcinomKina
-
Fudan UniversityIkke rekrutterer endnu
-
Guangzhou Institute of Respiratory DiseaseJiangsu HengRui Medicine Co., Ltd.; BGI-ShenzhenAfsluttetEsophageal pladecellekarcinom | ImmunterapiKina
-
Hebei Medical University Fourth HospitalRekruttering
-
Shanghai Gebaide Biotechnology Co., Ltd.UkendtIkke-småcellet lungekræft (NSCLC) Stadium IVKina
-
Aro BiotherapeuticsRekruttering
-
AstraZenecaAfsluttetSunde ældre | Mild-moderat Alzheimers sygdomForenede Stater
-
Shanghai Junshi Bioscience Co., Ltd.RekrutteringSmåcellet lungekræft i begrænset stadie (LS-SCLC)Kina, Frankrig, Forenede Stater, Spanien, Taiwan, Korea, Republikken, Kalkun, Italien, Holland, Georgien, Tyskland, Belgien, Polen, Rumænien
-
TKL Research, Inc.Nordson MicromedicsUkendtKorrektion af nasolabiale folderForenede Stater
-
Vivozon, Inc.AfsluttetPost-operative smerterKorea, Republikken
-
Shanghai Proton and Heavy Ion CenterRekrutteringNasopharyngealt karcinomKina
-
Peking Union Medical College HospitalRekrutteringTyktarmskræft | Immunterapi | Uoverensstemmelse reparationsmangelKina
-
Zhejiang Cancer HospitalRekruttering
-
Harbin Medical UniversityIkke rekrutterer endnuLungemetastaser | Kolorektal cancer metastatisk | Levermetastaser
-
Women's Hospital School Of Medicine Zhejiang UniversityRekrutteringStudy of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined ChemotherapyGestationel trofoblastisk neoplasiKina
-
Xijing HospitalRekruttering
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Rekruttering
-
Tongji HospitalRekruttering